Elizabeth Macnaught
Nurse Practitioner · Glen Burnie, MDNPI 1598528077
Payments from drug & device makers
Across 147 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$804
- Lilly USA, LLC$405
- AbbVie$253
- AstraZeneca$190
- Merck$163
- Dexcom, Inc.$133
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,053100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 36 | $804 |
| Lilly USA, LLC | 21 | $405 |
| AbbVie | 16 | $253 |
| AstraZeneca | 9 | $190 |
| Merck | 7 | $163 |
| Dexcom, Inc. | 7 | $133 |
| Boehringer Ingelheim | 6 | $131 |
| Pfizer | 7 | $129 |
| Exact Sciences | 4 | $85 |
| Astellas Pharma US Inc | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 2 | $66 |
| Bayer | 3 | $60 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $60 |
| Vertos Medical, Inc. | 1 | $59 |
| Globus Medical | 2 | $50 |
| Johnson & Johnson | 2 | $47 |
| Gilead | 2 | $42 |
| Lundbeck LLC | 2 | $41 |
| Medtronic | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Seqirus USA Inc | 1 | $29 |
| Dynavax Technologies Corporation | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $19 |
| TMS Neurohealth Centers Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| GSK | 1 | $17 |
| Insulet Corporation | 1 | $15 |
How this compares
$3,053 in reported general payments places this provider in the 90th percentile of 1,562 nurse practitioner providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 12 | $85 |
| Lisinopril | 11 | $56 |
| Azithromycin | 13 | $47 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Glen Burnie
- Morgan GaleRockville$292K
- Sherilyn BrinkleyBaltimore$100K
- Michelle TurnerBaltimore$94K
- Nelli ZafmanLutherville$67K
- Ellen LancasterFallston$52K
- Doris TateEaston$34K
- Zeev NemirovskyBaltimore$19K
- Martha ReilleyAnnapolis$18K
- Stephanie ZwonitzerAnnapolis$16K
- Jennifer MaglianoTimonium$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.